ES2417408R1 - Composiciones y cápsulas que comprenden cetilistat - Google Patents

Composiciones y cápsulas que comprenden cetilistat

Info

Publication number
ES2417408R1
ES2417408R1 ES201231973A ES201231973A ES2417408R1 ES 2417408 R1 ES2417408 R1 ES 2417408R1 ES 201231973 A ES201231973 A ES 201231973A ES 201231973 A ES201231973 A ES 201231973A ES 2417408 R1 ES2417408 R1 ES 2417408R1
Authority
ES
Spain
Prior art keywords
compositions
cetilistat
capsules
formulations
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201231973A
Other languages
English (en)
Other versions
ES2417408B1 (es
ES2417408A2 (es
Inventor
John Robert Bloor
Christopher Robert Dunk
Richard Michael John Palmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norgine BV
Original Assignee
Norgine BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1122213.0A external-priority patent/GB201122213D0/en
Priority claimed from GBGB1203082.1A external-priority patent/GB201203082D0/en
Application filed by Norgine BV filed Critical Norgine BV
Publication of ES2417408A2 publication Critical patent/ES2417408A2/es
Publication of ES2417408R1 publication Critical patent/ES2417408R1/es
Application granted granted Critical
Publication of ES2417408B1 publication Critical patent/ES2417408B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Logic Circuits (AREA)
  • Manipulation Of Pulses (AREA)

Abstract

La presente invención se refiere a composiciones que comprenden cetilistat, incluidas sus sales, esteres, amidas, solvatos, polimorfos y mezclas de éstos. La invención también se refiere a formulaciones que comprenden tales composiciones, a procesos para preparar las composiciones y formulaciones, y a sus métodos de empleo para el control del peso, incluida la pérdida de peso.
ES201231973A 2011-12-23 2012-12-20 Composiciones y cápsulas que comprenden cetilistat Expired - Fee Related ES2417408B1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1122213.0A GB201122213D0 (en) 2011-12-23 2011-12-23 Compositions
GB1122213 2011-12-23
GB1203082 2012-02-22
GBGB1203082.1A GB201203082D0 (en) 2012-02-22 2012-02-22 Compositions

Publications (3)

Publication Number Publication Date
ES2417408A2 ES2417408A2 (es) 2013-08-07
ES2417408R1 true ES2417408R1 (es) 2013-10-15
ES2417408B1 ES2417408B1 (es) 2014-11-26

Family

ID=47560448

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201231973A Expired - Fee Related ES2417408B1 (es) 2011-12-23 2012-12-20 Composiciones y cápsulas que comprenden cetilistat

Country Status (8)

Country Link
AU (1) AU2012101841A4 (es)
DK (1) DK201200198Y4 (es)
ES (1) ES2417408B1 (es)
FI (1) FI10194U1 (es)
FR (1) FR2984745B3 (es)
IE (1) IES20120556A2 (es)
IT (1) ITTO20121118A1 (es)
NL (1) NL2009995C2 (es)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US20090208584A1 (en) * 2005-06-09 2009-08-20 Tomohiro Yoshinari Solid preparation
US20110065697A1 (en) * 1999-01-08 2011-03-17 Norgine B.V. 2-oxy-benzoxazinone derivatives for the treatment of obesity
EP2423203A1 (en) * 2009-04-24 2012-02-29 Norgine BV Crystal of benzoxazinone compound

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US20110065697A1 (en) * 1999-01-08 2011-03-17 Norgine B.V. 2-oxy-benzoxazinone derivatives for the treatment of obesity
US20090208584A1 (en) * 2005-06-09 2009-08-20 Tomohiro Yoshinari Solid preparation
EP2423203A1 (en) * 2009-04-24 2012-02-29 Norgine BV Crystal of benzoxazinone compound

Also Published As

Publication number Publication date
FR2984745B3 (fr) 2017-12-22
NL2009995C2 (en) 2013-09-18
IES86183B2 (en) 2013-05-08
DK201200198U1 (en) 2013-04-12
NL2009995A (en) 2013-06-26
FR2984745A3 (fr) 2013-06-28
DK201200198Y4 (da) 2018-09-17
FI10194U1 (fi) 2013-08-20
AU2012101841A4 (en) 2013-01-17
ITTO20121118A1 (it) 2013-06-24
ES2417408B1 (es) 2014-11-26
ES2417408A2 (es) 2013-08-07
IES20120556A2 (en) 2013-05-08

Similar Documents

Publication Publication Date Title
DOP2016000144A (es) Moduladores de tetrahidropiridopirazinas de gpr6
CO7400867A2 (es) Modificador del sabor dulce
CR20160212A (es) Composiciones y métodos para modular los receptores x farnesoides
GT201400195A (es) Compuestos de heterociclilo como inhibidores de mek
BR112013003004A2 (pt) processos para a preparação de tubulisinas
CR20150370A (es) Compuestos antivirales
ECSP11011517A (es) Compuestos antivirales
CU20140089A7 (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
GT201400086A (es) Compuestos con actividad nematicida
NI201400036A (es) Compuestos con actividad nematicida
CU20140081A7 (es) Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
DOP2015000054A (es) Derivados de c17-alcandiilo y alquendiilo del ácido oleanólico y sus métodos de uso
CU20140095A7 (es) Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
UY33735A (es) Compuestos antivirales
ECSP14013215A (es) Compuestos novedosos
PE20171444A1 (es) Compuestos antivirales
CR20140554A (es) Compuestos de acido dimetil-benzoico
PE20180318A1 (es) Procedimiento para preparar isoquinolinonas y formas solidas de isoquinolinonas
DOP2018000062A (es) Piridinona dicaboxamidas para uso como inhibidores de bromodominio
NI201500050A (es) Benzamidas
CR20140435A (es) Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
CO2018004581A2 (es) Compuestos de criptoficina y productos conjugados, y sus métodos de preparación
CR20140553A (es) Compuestos de fenoxietil piperidina
CL2013003563A1 (es) Compuestos derivados de amidas del ácido gambógico y sus sales; composición farmacéutica que los comprende, útil en el tratamiento del glioblastoma.
ECSP11010807A (es) Sales de los compuestos del inhibidor de vih

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2417408

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20141126

FD2A Announcement of lapse in spain

Effective date: 20211004